Highlights Marksans Pharma Limited

Equities

MARKSANS

INE750C01026

Delayed NSE India S.E. Other stock markets 11:50:22 2024-09-09 pm EDT			5-day change	1st Jan Change
265.43 ^INR	+2.73%		+10.36%	+66.10%

Aug. 21	Marksans Pharma Arm Gets UK Regulator's Marketing Nod for Fluoxetine Capsules	MT
Aug. 20	Marksans Pharma Gets US FDA's EIR for Goa, India Unit	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Marksans Pharma Arm Gets UK Regulator's Marketing Nod for Fluoxetine Capsules	Aug. 21	MT
Marksans Pharma Gets US FDA's EIR for Goa, India Unit	Aug. 20	MT
Successful Closure of US FDA Inspection At Marksans Pharma's Manufacturing Facility Located At Verna, Goa	Aug. 20	CI
Marksans Pharma Seeks M&A	Aug. 14	CI
Marksans Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	Aug. 13	CI
Marksans Pharma Arm Gets UK Regulator's Nod for Levonorgestrel Tablet	Aug. 02	MT
Marksans Pharma Gets UK Regulator's Nod for Two Products	Jul. 02	MT
INDIA STOCKS-Indian shares fall for fifth session on weak global cues, election uncertainties	May. 30	RE
Marksans Pharma's Consolidated Profit Declines in Fiscal Q4; Shares Fall 9%	May. 30	MT
Marksans Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 30	CI
Marksans Pharma Limited Recommends Final Dividend for the Financial Year 2023-24	May. 30	CI
Marksans Pharma Gets Marketing Approval for Levetiracetam Relonchem in UK	May. 28	MT
Marksans Pharma's Goa Facility Gets Five Inspectional Observations from US FDA	Apr. 18	MT
Marksans Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 13	CI
Marksans Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
Marksans Pharma Arm Gets UK Regulator's Approval to Market Cyanocobalamin Tablets	Nov. 06	MT
Marksans Pharma Undergoes Successful Inspection from German Health Authorities	Nov. 01	MT
Marksans Pharma Gets US FDA Nod for Esomeprazole Magnesium Delayed-Release Capsules	23-10-03	MT
Marksans Pharma Limited Announces US FDA Approval for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg	23-10-03	CI
Marksans Pharma Limited Approves Payment of Dividend	23-08-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Marksans Pharma Limited

Equities

MARKSANS

INE750C01026

Highlights

Filters